IXICO
@ixico.bsky.social
A global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
We'll be at GAP‑NET Site Optimisation Summit (Feb 25–27)!
Meet our team:
Jackie Barrett | Michelle Lax | Robin Wolz
🎙️ Feb 26: Robin speaks on Early Detection + tech advances.
⚡ Jackie will be talking about our involvement in Bio-Hermess002
Connect with us 👉 www.ixico.com/contact-us
Meet our team:
Jackie Barrett | Michelle Lax | Robin Wolz
🎙️ Feb 26: Robin speaks on Early Detection + tech advances.
⚡ Jackie will be talking about our involvement in Bio-Hermess002
Connect with us 👉 www.ixico.com/contact-us
February 12, 2026 at 1:05 PM
We'll be at GAP‑NET Site Optimisation Summit (Feb 25–27)!
Meet our team:
Jackie Barrett | Michelle Lax | Robin Wolz
🎙️ Feb 26: Robin speaks on Early Detection + tech advances.
⚡ Jackie will be talking about our involvement in Bio-Hermess002
Connect with us 👉 www.ixico.com/contact-us
Meet our team:
Jackie Barrett | Michelle Lax | Robin Wolz
🎙️ Feb 26: Robin speaks on Early Detection + tech advances.
⚡ Jackie will be talking about our involvement in Bio-Hermess002
Connect with us 👉 www.ixico.com/contact-us
Pleased to announced the extension of our neuroimaging work with one of the world's leading pharmaceutical companies following the continued progress of a Phase 2 clinical trial in Huntington’s Disease.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
February 12, 2026 at 7:08 AM
Pleased to announced the extension of our neuroimaging work with one of the world's leading pharmaceutical companies following the continued progress of a Phase 2 clinical trial in Huntington’s Disease.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
2 weeks until HDTC 2026!
We’ll be sharing our poster comparing automated volumetric methods with the Boundary Shift Integral + manual segmentation — key insights for HD imaging.
Catch Michelle Lax & Robin Wolz onsite.
Book time → www.ixico.com/contact-us
We’ll be sharing our poster comparing automated volumetric methods with the Boundary Shift Integral + manual segmentation — key insights for HD imaging.
Catch Michelle Lax & Robin Wolz onsite.
Book time → www.ixico.com/contact-us
February 10, 2026 at 1:35 PM
2 weeks until HDTC 2026!
We’ll be sharing our poster comparing automated volumetric methods with the Boundary Shift Integral + manual segmentation — key insights for HD imaging.
Catch Michelle Lax & Robin Wolz onsite.
Book time → www.ixico.com/contact-us
We’ll be sharing our poster comparing automated volumetric methods with the Boundary Shift Integral + manual segmentation — key insights for HD imaging.
Catch Michelle Lax & Robin Wolz onsite.
Book time → www.ixico.com/contact-us
We're gearing up for the GAP‑NET Site Optimisation Summit (Feb 25–27)!
Meet the team:
Jackie Barrett | Michelle Lax | Prof. Robin Wolz
Feb 26: Robin speaks on Early Detection + tech advances.
Jackie presents: “2 mins – 2 slides” on work on Bio‑Hermes 002
Connect with us 👉 www.ixico.com/contact-us
Meet the team:
Jackie Barrett | Michelle Lax | Prof. Robin Wolz
Feb 26: Robin speaks on Early Detection + tech advances.
Jackie presents: “2 mins – 2 slides” on work on Bio‑Hermes 002
Connect with us 👉 www.ixico.com/contact-us
February 5, 2026 at 2:42 PM
We're gearing up for the GAP‑NET Site Optimisation Summit (Feb 25–27)!
Meet the team:
Jackie Barrett | Michelle Lax | Prof. Robin Wolz
Feb 26: Robin speaks on Early Detection + tech advances.
Jackie presents: “2 mins – 2 slides” on work on Bio‑Hermes 002
Connect with us 👉 www.ixico.com/contact-us
Meet the team:
Jackie Barrett | Michelle Lax | Prof. Robin Wolz
Feb 26: Robin speaks on Early Detection + tech advances.
Jackie presents: “2 mins – 2 slides” on work on Bio‑Hermes 002
Connect with us 👉 www.ixico.com/contact-us
We’re getting ready for HDTC 2026 (Feb 23–25)!
Representing IXICO:
Michelle Lax — VP Imaging & Commercial
Robin Wolz — Chief Scientific & Medical Officer
If you’re attending and want to meet up → www.ixico.com/contact-us
Representing IXICO:
Michelle Lax — VP Imaging & Commercial
Robin Wolz — Chief Scientific & Medical Officer
If you’re attending and want to meet up → www.ixico.com/contact-us
February 3, 2026 at 11:00 AM
We’re getting ready for HDTC 2026 (Feb 23–25)!
Representing IXICO:
Michelle Lax — VP Imaging & Commercial
Robin Wolz — Chief Scientific & Medical Officer
If you’re attending and want to meet up → www.ixico.com/contact-us
Representing IXICO:
Michelle Lax — VP Imaging & Commercial
Robin Wolz — Chief Scientific & Medical Officer
If you’re attending and want to meet up → www.ixico.com/contact-us
Heading to HDTC 2026 on Feb 23–25!
We’re presenting our poster on automated volumetric analysis methods in Huntington’s disease — comparing them with the Boundary Shift Integral + manual segmentation.
If you’re attending and want to connect: www.ixico.com/contact-us
We’re presenting our poster on automated volumetric analysis methods in Huntington’s disease — comparing them with the Boundary Shift Integral + manual segmentation.
If you’re attending and want to connect: www.ixico.com/contact-us
January 28, 2026 at 1:41 PM
Heading to HDTC 2026 on Feb 23–25!
We’re presenting our poster on automated volumetric analysis methods in Huntington’s disease — comparing them with the Boundary Shift Integral + manual segmentation.
If you’re attending and want to connect: www.ixico.com/contact-us
We’re presenting our poster on automated volumetric analysis methods in Huntington’s disease — comparing them with the Boundary Shift Integral + manual segmentation.
If you’re attending and want to connect: www.ixico.com/contact-us
The progress towards a scalable blood‑based test for Alzheimer’s disease represents a pivotal moment in early detection.
IXICO supports this progress as imaging partner for the Bio‑Hermes‑002 study with @GAP_Foundation, @lifearc1 and @UKDRI
www.bbc.co.uk/news/article...
IXICO supports this progress as imaging partner for the Bio‑Hermes‑002 study with @GAP_Foundation, @lifearc1 and @UKDRI
www.bbc.co.uk/news/article...
January 20, 2026 at 9:46 AM
The progress towards a scalable blood‑based test for Alzheimer’s disease represents a pivotal moment in early detection.
IXICO supports this progress as imaging partner for the Bio‑Hermes‑002 study with @GAP_Foundation, @lifearc1 and @UKDRI
www.bbc.co.uk/news/article...
IXICO supports this progress as imaging partner for the Bio‑Hermes‑002 study with @GAP_Foundation, @lifearc1 and @UKDRI
www.bbc.co.uk/news/article...
Blog: Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics
📥 Missed us at HAI 2025? Here’s a summary of our poster in this blog: ixico.com/news-and-res...
📥 Missed us at HAI 2025? Here’s a summary of our poster in this blog: ixico.com/news-and-res...
January 14, 2026 at 11:55 AM
Blog: Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics
📥 Missed us at HAI 2025? Here’s a summary of our poster in this blog: ixico.com/news-and-res...
📥 Missed us at HAI 2025? Here’s a summary of our poster in this blog: ixico.com/news-and-res...
Thank you to everyone who visited us at our poster at HAI 2026!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 71)
If you’re around at HAI 2026, let’s meet! www.ixico.com/contact-us
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 71)
If you’re around at HAI 2026, let’s meet! www.ixico.com/contact-us
January 13, 2026 at 6:25 PM
Thank you to everyone who visited us at our poster at HAI 2026!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 71)
If you’re around at HAI 2026, let’s meet! www.ixico.com/contact-us
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 71)
If you’re around at HAI 2026, let’s meet! www.ixico.com/contact-us
We're here at HAI 2025!
Robin Wolz and Jane Waugh will be around to present and talk with the community!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET #71
Let's meet - www.ixico.com/contact-us
Robin Wolz and Jane Waugh will be around to present and talk with the community!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET #71
Let's meet - www.ixico.com/contact-us
January 13, 2026 at 9:56 AM
We're here at HAI 2025!
Robin Wolz and Jane Waugh will be around to present and talk with the community!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET #71
Let's meet - www.ixico.com/contact-us
Robin Wolz and Jane Waugh will be around to present and talk with the community!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET #71
Let's meet - www.ixico.com/contact-us
Next week, we’ll be at HAI 2026 in San Juan!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 208)
Let’s connect: www.ixico.com/contact-us
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 208)
Let’s connect: www.ixico.com/contact-us
January 8, 2026 at 11:37 AM
Next week, we’ll be at HAI 2026 in San Juan!
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 208)
Let’s connect: www.ixico.com/contact-us
📌 Poster: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET (ID: 208)
Let’s connect: www.ixico.com/contact-us
We'll be at HAI 2026 in San Juan, Puerto Rico!
Robin Wolz and Jane Waugh will be there to discuss advances in Alzheimer’s imaging.
📌 Poster: Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET
Robin Wolz and Jane Waugh will be there to discuss advances in Alzheimer’s imaging.
📌 Poster: Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET
December 17, 2025 at 2:51 PM
We'll be at HAI 2026 in San Juan, Puerto Rico!
Robin Wolz and Jane Waugh will be there to discuss advances in Alzheimer’s imaging.
📌 Poster: Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET
Robin Wolz and Jane Waugh will be there to discuss advances in Alzheimer’s imaging.
📌 Poster: Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET
Imaging is key in Parkinson’s clinical research—but getting it right matters.
From modality selection to operational best practices, our quick guide covers the essentials for successful imaging in trials.
Read more: ixico.com/news-and-res...
From modality selection to operational best practices, our quick guide covers the essentials for successful imaging in trials.
Read more: ixico.com/news-and-res...
December 10, 2025 at 11:42 AM
Imaging is key in Parkinson’s clinical research—but getting it right matters.
From modality selection to operational best practices, our quick guide covers the essentials for successful imaging in trials.
Read more: ixico.com/news-and-res...
From modality selection to operational best practices, our quick guide covers the essentials for successful imaging in trials.
Read more: ixico.com/news-and-res...
Today IXICO announced its 2025 financial results demonstrating how the disciplined execution of its “Innovate Lead Scale" strategy has delivered 13% revenue growth with commercial traction further accelerating into FY26.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
December 9, 2025 at 7:12 AM
Today IXICO announced its 2025 financial results demonstrating how the disciplined execution of its “Innovate Lead Scale" strategy has delivered 13% revenue growth with commercial traction further accelerating into FY26.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
Good to see new and familiar faces at CTAD 2025. Great energy, enthusiasm and innovation from the Alzheimer’s research community, bringing new diagnosis, treatment and care approaches to patients.
December 4, 2025 at 2:01 PM
Good to see new and familiar faces at CTAD 2025. Great energy, enthusiasm and innovation from the Alzheimer’s research community, bringing new diagnosis, treatment and care approaches to patients.
Neuromelanin-sensitive (NM) MRI is emerging as a transformative tool in Parkinson's clinical research. In this blog, Richard Joules, Associate Director R&D, explores the evolving role of Neuromelanin imaging in Parkinson's disease clinical trials.
Read more:
🔗 ixico.com/blogs/the-em...
Read more:
🔗 ixico.com/blogs/the-em...
December 3, 2025 at 10:27 AM
Neuromelanin-sensitive (NM) MRI is emerging as a transformative tool in Parkinson's clinical research. In this blog, Richard Joules, Associate Director R&D, explores the evolving role of Neuromelanin imaging in Parkinson's disease clinical trials.
Read more:
🔗 ixico.com/blogs/the-em...
Read more:
🔗 ixico.com/blogs/the-em...
GLP-1 therapies are attracting attention and traction in Alzheimer’s research, but vascular co-pathology remains a critical factor in trial design. In the run-up to #CTAD2025, IXICO CSO Robin Wolz explains why vascular phenotyping matters.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
December 1, 2025 at 10:56 AM
GLP-1 therapies are attracting attention and traction in Alzheimer’s research, but vascular co-pathology remains a critical factor in trial design. In the run-up to #CTAD2025, IXICO CSO Robin Wolz explains why vascular phenotyping matters.
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
To coincide with IXICO’s participation in the 18th CTAD conference we are delighted to announce the appointment of two leading global experts in the field of Alzheimer’s Disease (AD) and cerebrovascular disease (CVD) as advisors.
Read more here: ixico.com/news-and-res...
Read more here: ixico.com/news-and-res...
December 1, 2025 at 7:14 AM
To coincide with IXICO’s participation in the 18th CTAD conference we are delighted to announce the appointment of two leading global experts in the field of Alzheimer’s Disease (AD) and cerebrovascular disease (CVD) as advisors.
Read more here: ixico.com/news-and-res...
Read more here: ixico.com/news-and-res...
We’re heading to #CTAD2025 next week in San Diego (Dec 1–4)!
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
November 26, 2025 at 11:18 AM
We’re heading to #CTAD2025 next week in San Diego (Dec 1–4)!
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
Let’s connect at #CTAD2025 (Dec 1–4)
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st–2nd
📩 ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st–2nd
📩 ixico.com/contact-us
November 19, 2025 at 12:23 PM
Let’s connect at #CTAD2025 (Dec 1–4)
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st–2nd
📩 ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st–2nd
📩 ixico.com/contact-us
Today, IXICO announce it has won a new commercial contract with a global pharmaceutical company to provide imaging services for a worldwide Phase 3 clinical trial in Huntington’s Disease (HD).
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
November 17, 2025 at 7:08 AM
Today, IXICO announce it has won a new commercial contract with a global pharmaceutical company to provide imaging services for a worldwide Phase 3 clinical trial in Huntington’s Disease (HD).
Read more: ixico.com/news-and-res...
Read more: ixico.com/news-and-res...
We’re attending #CTAD2025 in San Diego (Dec 1–4)!
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
November 11, 2025 at 2:10 PM
We’re attending #CTAD2025 in San Diego (Dec 1–4)!
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
🧠 Poster P173: Harmonization Via Smoothing to A Common Spatial Resolution Yields Modest Benefits in Amyloid PET
📅 Dec 1st (3:00 PM) – Dec 2nd (5:30 PM)
📩 Connect: ixico.com/contact-us
Integrating plasma biomarkers with MRI is reshaping Alzheimer's clinical trials. This dual approach improves enrolment precision, reduces screen failures & boosts efficiency.
Read here:
🔗 ixico.com/news-and-res...
Read here:
🔗 ixico.com/news-and-res...
October 28, 2025 at 4:41 PM
Integrating plasma biomarkers with MRI is reshaping Alzheimer's clinical trials. This dual approach improves enrolment precision, reduces screen failures & boosts efficiency.
Read here:
🔗 ixico.com/news-and-res...
Read here:
🔗 ixico.com/news-and-res...
James Chandler, Chief Business Officer at IXICO, will be at BIO-Europe in Vienna, Austria, on November 3–5!
If you are attending, let's connect!
🔗partneringONE portal: partneringone.informaconnect.com/sign-in?even...
🔗Contact us: www.ixico.com/contact-us
If you are attending, let's connect!
🔗partneringONE portal: partneringone.informaconnect.com/sign-in?even...
🔗Contact us: www.ixico.com/contact-us
October 23, 2025 at 11:40 AM
James Chandler, Chief Business Officer at IXICO, will be at BIO-Europe in Vienna, Austria, on November 3–5!
If you are attending, let's connect!
🔗partneringONE portal: partneringone.informaconnect.com/sign-in?even...
🔗Contact us: www.ixico.com/contact-us
If you are attending, let's connect!
🔗partneringONE portal: partneringone.informaconnect.com/sign-in?even...
🔗Contact us: www.ixico.com/contact-us
🧠 Happening Tomorrow!
Join us Oct 22 for a deep dive into Alzheimer’s imaging, comorbidities & emerging targets.
🧠 Register now: ixico.com/news-and-res...
Join us Oct 22 for a deep dive into Alzheimer’s imaging, comorbidities & emerging targets.
🧠 Register now: ixico.com/news-and-res...
October 21, 2025 at 12:01 PM
🧠 Happening Tomorrow!
Join us Oct 22 for a deep dive into Alzheimer’s imaging, comorbidities & emerging targets.
🧠 Register now: ixico.com/news-and-res...
Join us Oct 22 for a deep dive into Alzheimer’s imaging, comorbidities & emerging targets.
🧠 Register now: ixico.com/news-and-res...